PAG
IMUX icon

Private Advisor Group’s Immunic IMUX Stock Holding History

Private Advisor Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$11.1K – 2703
2026
Q1 		$11.1K Hold
1,000
– – ﹤0.01% 2638
2025
Q4 		$5.34K Hold
1,000
– – ﹤0.01% 2582
2025
Q3 		$8.82K Hold
1,000
– – ﹤0.01% 2511
2025
Q2 		$6.98K Hold
1,000
– – ﹤0.01% 2422
2025
Q1 		$10.9K Hold
1,000
– – ﹤0.01% 2284
2024
Q4 		$10K Hold
1,000
– – ﹤0.01% 2253
2024
Q3 		$16.5K Hold
1,000
– – ﹤0.01% 2380
2024
Q2 		$11.1K Hold
1,000
– – ﹤0.01% 2313
2024
Q1 		$13.2K Hold
1,000
– – ﹤0.01% 2276
2023
Q4 		$15K Buy
+1,000
New +$12.3K ﹤0.01% 2200

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Private Advisor Group's IMUX Position: Q2 2026 in Review

Private Advisor Group sold out of Immunic (IMUX) in Q2 2026, closing a stake of 1,000 shares — an estimated $11.1K sold.

Private Advisor Group first reported a position in IMUX in Q4 2023 and held it in 10 quarters. The position peaked at $16.5K in Q3 2024. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Private Advisor Group reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 1,000 Immunic shares in Q2 2026, an estimated $11.1K.
  • Private Advisor Group first reported a position in Immunic in Q4 2023 and held it in 10 quarters.
  • Private Advisor Group's Immunic position peaked at $16.5K in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.